One of the top pharmaceutical firms in the nation is Torrent Pharma, the flagship business of the Torrent Group. The Company is considered one of the leaders in the therapeutic segments of women's healthcare (WHC), cardiovascular (CV), central nervous system (CNS), and gastrointestinal (GI) healthcare. The Company was a pioneer in introducing the concept of niche marketing in India. Additionally, the company is well-represented in the oncology, gynecology, diabetology, pain management, and anti-infective categories.
Torrent Pharma's competitive edge is derived from its top-notch manufacturing facilities, cutting-edge research and development capabilities, vast domestic network, and global presence spanning over 40 countries.
Torrent Pharma's position in the Indian Pharma market was strengthened by the acquisition of Elder Pharma's Indian branded business in 2013, Zyg Pharma's dermatological business in 2015, Glochem Industries' API plant in 2016, women's healthcare brands from Novartis, Unichem's Indian branded business along with its Sikkim Plant in 2017, and Curatio in 2022.
In order to break into the German market, Torrent Pharma began making foreign acquisitions in 2005 when it acquired 90-year-old Heumann from Pfizer. Later in 2015, ANDA of minocycline was acquired by Ranbaxy for the US market.
Additionally, in January 2018, Torrent purchased Levittown, Pennsylvania-based Bio-Pharm, Inc. (BPI), an OTC and generic drug company.
Torrent Pharma is dedicated to providing "lifecare, not just healthcare."